• Login
    View Item 
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Research papers (Caprisa)
    • View Item
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Research papers (Caprisa)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate Human Immunodeficiency Virus Type 1 vaccines.

    Thumbnail
    View/Open
    Journal article (85.41Kb)
    Date
    2005
    Author
    Mascola, John R.
    D'Souza, Patricia.
    Gilbert, Peter.
    Hahn, Beatrice H.
    Haigwood, Nancy L.
    Morris, Lynn.
    Petropoulos, Christos J.
    Polonis, Victoria R.
    Sarzotti, Marcella.
    Montefiori, David C.
    Metadata
    Show full item record
    Abstract
    No abstract available.
    URI
    http://dx.doi.org/10.1128/JVI.79.16.10103–10107.2005
    http://hdl.handle.net/10413/8828
    Collections
    • Research papers (Caprisa) [447]

    Related items

    Showing items related by title, author, creator and subject.

    • Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. 

      Gray, Glenda E.; Allen, Mary.; Moodie, Zoe.; Churchyard, Gavin J.; Bekker, Linda-Gail.; Nchabeleng, Maphoshane.; Mlisana, Koleka Patience.; Metch, Barbara.; De Bruyn, Guy.; Latka, Mary H.; Roux, Surita.; Mathebula, Matsontso.; Naicker, Nivashnee.; Ducar, Constance.; Carter, Donald K.; Puren, Adrian.; Eaton, Niles.; McElrath, M. Juliana.; Robertson, Michael.; Corey, Lawrence.; Kublin, James. (Elsevier., 2011)
      Background. The MRKAd5 HIV-1 gag/pol/nef subtype B vaccine was designed to elicit T-cell-mediated immune responses capable of providing complete or partial protection from HIV-1 infection or a decrease in viral load after ...
    • Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? 

      Gray, Glenda E.; Metch, Barbara.; Churchyard, Gavin J.; Mlisana, Koleka Patience.; Nchabeleng, Maphoshane.; Allen, Mary.; Moodie, Zoe.; Kublin, James.; Bekker, Linda-Gail. (Elsevier., 2012)
      Background: Increased sexual risk behaviour in participants enrolled in HIV prevention trials has been a concern. The HVTN 503/Phambili study, a phase 2B study of the Merck Ad-5 multiclade HIV vaccine in South Africa, ...
    • Testing for passive transfer of immunity in foals, and an evaluation of the African horse sickness vaccination schedule. 

      Crow, Linnet Jean Isobel. (2005)
      This thesis comprises an introductory review of the literature, followed by reports of two experiments which are presented in the form of scientific papers. For this reason, there may be some repetition between chapters, ...

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisorsTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsAdvisorsType

    My Account

    LoginRegister

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV